Saviano A, De Vita S, Chini M, Marigliano N, Lauro G, Casillo G
Biomolecules. 2022; 12(1).
PMID: 35053247
PMC: 8774285.
DOI: 10.3390/biom12010099.
Gu Y, Liu W, Liu G, Li X, Lu P
Mol Med Rep. 2021; 24(4).
PMID: 34435647
PMC: 8404095.
DOI: 10.3892/mmr.2021.12379.
Zhu F, Chen H, Xu M, Zhang X, Yu J, Pan Y
Pharm Biol. 2021; 59(1):465-471.
PMID: 33915069
PMC: 8871624.
DOI: 10.1080/13880209.2021.1914672.
Fu L, Han B, Zhou Y, Ren J, Cao W, Patel G
Front Pharmacol. 2020; 11:193.
PMID: 32265690
PMC: 7098175.
DOI: 10.3389/fphar.2020.00193.
Teimoori-Boghsani Y, Ganjeali A, Cernava T, Muller H, Asili J, Berg G
Front Microbiol. 2020; 10:3013.
PMID: 32010087
PMC: 6978743.
DOI: 10.3389/fmicb.2019.03013.
A Novel Tanshinone Analog Exerts Anti-Cancer Effects in Prostate Cancer by Inducing Cell Apoptosis, Arresting Cell Cycle at G2 Phase and Blocking Metastatic Ability.
Wang M, Zeng X, Li S, Sun Z, Yu J, Chen C
Int J Mol Sci. 2019; 20(18).
PMID: 31510010
PMC: 6770861.
DOI: 10.3390/ijms20184459.
Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.
Li Z, Xu S, Liu P
Acta Pharmacol Sin. 2018; 39(5):802-824.
PMID: 29698387
PMC: 5943903.
DOI: 10.1038/aps.2017.193.
Cryptotanshinone exhibits therapeutical effects on cerebral stroke through the PI3K/AKT‑eNOS signaling pathway.
Zhu W, Qiu W, Lu A
Mol Med Rep. 2017; 16(6):9361-9366.
PMID: 29152647
PMC: 5779989.
DOI: 10.3892/mmr.2017.7824.
Cryptotanshinone reverses reproductive disturbances in rats with dehydroepiandrosterone-induced polycystic ovary syndrome.
Xia Y, Zhao P, Huang H, Xie Y, Lu R, Dong L
Am J Transl Res. 2017; 9(5):2447-2456.
PMID: 28559995
PMC: 5446527.
Cryptotanshinone potentiates the antitumor effects of doxorubicin on gastric cancer cells via inhibition of STAT3 activity.
Wang J, Zhang G, Dai C, Gao X, Wu J, Shen L
J Int Med Res. 2017; 45(1):220-230.
PMID: 28222632
PMC: 5536615.
DOI: 10.1177/0300060516685513.
Cryptotanshinone targets tumor-initiating cells through down-regulation of stemness genes expression.
Zhang Y, Cabarcas S, Zheng J, Sun L, Mathews L, Zhang X
Oncol Lett. 2016; 11(6):3803-3812.
PMID: 27313698
PMC: 4888080.
DOI: 10.3892/ol.2016.4444.
The effects and possible mechanisms of puerarin to treat endometriosis model rats.
Yu J, Zhao L, Zhang D, Zhai D, Shen W, Bai L
Evid Based Complement Alternat Med. 2015; 2015:269138.
PMID: 25815028
PMC: 4359829.
DOI: 10.1155/2015/269138.
Cryptotanshinone inhibits breast cancer cell growth by suppressing estrogen receptor signaling.
Li S, Wang H, Hong L, Liu W, Huang F, Wang J
Cancer Biol Ther. 2014; 16(1):176-84.
PMID: 25482936
PMC: 4622426.
DOI: 10.4161/15384047.2014.962960.
Cryptotanshinone Reverses Reproductive and Metabolic Disturbances in PCOS Model Rats via Regulating the Expression of CYP17 and AR.
Yu J, Zhai D, Hao L, Zhang D, Bai L, Cai Z
Evid Based Complement Alternat Med. 2014; 2014:670743.
PMID: 24799941
PMC: 3996859.
DOI: 10.1155/2014/670743.
Inhibitory effect of cryptotanshinone on angiogenesis and Wnt/β-catenin signaling pathway in human umbilical vein endothelial cells.
Chen Q, Zhuang Q, Mao W, Xu X, Wang L, Wang H
Chin J Integr Med. 2014; 20(10):743-50.
PMID: 24740553
DOI: 10.1007/s11655-014-1810-x.
Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells.
Jung J, Kwon T, Jeong S, Kim E, Sohn E, Yun M
Evid Based Complement Alternat Med. 2013; 2013:805639.
PMID: 23878608
PMC: 3710643.
DOI: 10.1155/2013/805639.
Molecular evidence of cryptotanshinone for treatment and prevention of human cancer.
Chen W, Lu Y, Chen G, Huang S
Anticancer Agents Med Chem. 2013; 13(7):979-87.
PMID: 23272908
PMC: 3625674.
DOI: 10.2174/18715206113139990115.
Inhibition of Hypoxia Inducible Factor Alpha and Astrocyte-Elevated Gene-1 Mediates Cryptotanshinone Exerted Antitumor Activity in Hypoxic PC-3 Cells.
Lee H, Jung D, Sohn E, Kim H, Park M, Lew J
Evid Based Complement Alternat Med. 2012; 2012:390957.
PMID: 23243443
PMC: 3519236.
DOI: 10.1155/2012/390957.
Tanshinones: sources, pharmacokinetics and anti-cancer activities.
Zhang Y, Jiang P, Ye M, Kim S, Jiang C, Lu J
Int J Mol Sci. 2012; 13(10):13621-66.
PMID: 23202971
PMC: 3497345.
DOI: 10.3390/ijms131013621.
Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E.
Ge Y, Cheng R, Zhou Y, Shen J, Peng L, Xu X
Mol Cell Biochem. 2012; 368(1-2):17-25.
PMID: 22614784
DOI: 10.1007/s11010-012-1338-3.